The global 3D Bioprinting for Tissue and Organ Regeneration market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for 3D Bioprinting for Tissue and Organ Regeneration is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for 3D Bioprinting for Tissue and Organ Regeneration is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for 3D Bioprinting for Tissue and Organ Regeneration in Clinical Applications is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of 3D Bioprinting for Tissue and Organ Regeneration include BIOLIFE4D, Organovo, Celllink, Aspect Biosystems, Cyfuse Biomedical, TeVido Biodevices, Digilab, Advanced Solutions Life Sciences and TRS – Tissue Regeneration Systems, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for 3D Bioprinting for Tissue and Organ Regeneration, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3D Bioprinting for Tissue and Organ Regeneration.
Report Scope
The 3D Bioprinting for Tissue and Organ Regeneration market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global 3D Bioprinting for Tissue and Organ Regeneration market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 3D Bioprinting for Tissue and Organ Regeneration companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BIOLIFE4D
Organovo
Celllink
Aspect Biosystems
Cyfuse Biomedical
TeVido Biodevices
Digilab
Advanced Solutions Life Sciences
TRS – Tissue Regeneration Systems
Nscrypt, Inc
EnvisionTEC
MedPrin
Nano3D Sciences
Rokit
Cellbricks
REGEMAT 3D
Allevi
Poietis
T&R BIOFAB
Segment by Type
Magnetic 3D Bioprinting
Laser-assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
Segment by Application
Clinical Applications
Research Applications
Drug and Medical Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 3D Bioprinting for Tissue and Organ Regeneration companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global 3D Bioprinting for Tissue and Organ Regeneration Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Magnetic 3D Bioprinting
1.2.3 Laser-assisted Bioprinting
1.2.4 Inkjet 3D Bioprinting
1.2.5 Microextrusion 3D Bioprinting
1.3 Market by Application
1.3.1 Global 3D Bioprinting for Tissue and Organ Regeneration Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Applications
1.3.3 Research Applications
1.3.4 Drug and Medical Research
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global 3D Bioprinting for Tissue and Organ Regeneration Market Perspective (2019-2030)
2.2 3D Bioprinting for Tissue and Organ Regeneration Growth Trends by Region
2.2.1 Global 3D Bioprinting for Tissue and Organ Regeneration Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 3D Bioprinting for Tissue and Organ Regeneration Historic Market Size by Region (2019-2024)
2.2.3 3D Bioprinting for Tissue and Organ Regeneration Forecasted Market Size by Region (2025-2030)
2.3 3D Bioprinting for Tissue and Organ Regeneration Market Dynamics
2.3.1 3D Bioprinting for Tissue and Organ Regeneration Industry Trends
2.3.2 3D Bioprinting for Tissue and Organ Regeneration Market Drivers
2.3.3 3D Bioprinting for Tissue and Organ Regeneration Market Challenges
2.3.4 3D Bioprinting for Tissue and Organ Regeneration Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top 3D Bioprinting for Tissue and Organ Regeneration Players by Revenue
3.1.1 Global Top 3D Bioprinting for Tissue and Organ Regeneration Players by Revenue (2019-2024)
3.1.2 Global 3D Bioprinting for Tissue and Organ Regeneration Revenue Market Share by Players (2019-2024)
3.2 Global 3D Bioprinting for Tissue and Organ Regeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by 3D Bioprinting for Tissue and Organ Regeneration Revenue
3.4 Global 3D Bioprinting for Tissue and Organ Regeneration Market Concentration Ratio
3.4.1 Global 3D Bioprinting for Tissue and Organ Regeneration Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by 3D Bioprinting for Tissue and Organ Regeneration Revenue in 2023
3.5 3D Bioprinting for Tissue and Organ Regeneration Key Players Head office and Area Served
3.6 Key Players 3D Bioprinting for Tissue and Organ Regeneration Product Solution and Service
3.7 Date of Enter into 3D Bioprinting for Tissue and Organ Regeneration Market
3.8 Mergers & Acquisitions, Expansion Plans
4 3D Bioprinting for Tissue and Organ Regeneration Breakdown Data by Type
4.1 Global 3D Bioprinting for Tissue and Organ Regeneration Historic Market Size by Type (2019-2024)
4.2 Global 3D Bioprinting for Tissue and Organ Regeneration Forecasted Market Size by Type (2025-2030)
5 3D Bioprinting for Tissue and Organ Regeneration Breakdown Data by Application
5.1 Global 3D Bioprinting for Tissue and Organ Regeneration Historic Market Size by Application (2019-2024)
5.2 Global 3D Bioprinting for Tissue and Organ Regeneration Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America 3D Bioprinting for Tissue and Organ Regeneration Market Size (2019-2030)
6.2 North America 3D Bioprinting for Tissue and Organ Regeneration Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America 3D Bioprinting for Tissue and Organ Regeneration Market Size by Country (2019-2024)
6.4 North America 3D Bioprinting for Tissue and Organ Regeneration Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe 3D Bioprinting for Tissue and Organ Regeneration Market Size (2019-2030)
7.2 Europe 3D Bioprinting for Tissue and Organ Regeneration Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe 3D Bioprinting for Tissue and Organ Regeneration Market Size by Country (2019-2024)
7.4 Europe 3D Bioprinting for Tissue and Organ Regeneration Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific 3D Bioprinting for Tissue and Organ Regeneration Market Size (2019-2030)
8.2 Asia-Pacific 3D Bioprinting for Tissue and Organ Regeneration Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific 3D Bioprinting for Tissue and Organ Regeneration Market Size by Region (2019-2024)
8.4 Asia-Pacific 3D Bioprinting for Tissue and Organ Regeneration Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America 3D Bioprinting for Tissue and Organ Regeneration Market Size (2019-2030)
9.2 Latin America 3D Bioprinting for Tissue and Organ Regeneration Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America 3D Bioprinting for Tissue and Organ Regeneration Market Size by Country (2019-2024)
9.4 Latin America 3D Bioprinting for Tissue and Organ Regeneration Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa 3D Bioprinting for Tissue and Organ Regeneration Market Size (2019-2030)
10.2 Middle East & Africa 3D Bioprinting for Tissue and Organ Regeneration Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa 3D Bioprinting for Tissue and Organ Regeneration Market Size by Country (2019-2024)
10.4 Middle East & Africa 3D Bioprinting for Tissue and Organ Regeneration Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BIOLIFE4D
11.1.1 BIOLIFE4D Company Detail
11.1.2 BIOLIFE4D Business Overview
11.1.3 BIOLIFE4D 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.1.4 BIOLIFE4D Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.1.5 BIOLIFE4D Recent Development
11.2 Organovo
11.2.1 Organovo Company Detail
11.2.2 Organovo Business Overview
11.2.3 Organovo 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.2.4 Organovo Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.2.5 Organovo Recent Development
11.3 Celllink
11.3.1 Celllink Company Detail
11.3.2 Celllink Business Overview
11.3.3 Celllink 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.3.4 Celllink Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.3.5 Celllink Recent Development
11.4 Aspect Biosystems
11.4.1 Aspect Biosystems Company Detail
11.4.2 Aspect Biosystems Business Overview
11.4.3 Aspect Biosystems 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.4.4 Aspect Biosystems Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.4.5 Aspect Biosystems Recent Development
11.5 Cyfuse Biomedical
11.5.1 Cyfuse Biomedical Company Detail
11.5.2 Cyfuse Biomedical Business Overview
11.5.3 Cyfuse Biomedical 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.5.4 Cyfuse Biomedical Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.5.5 Cyfuse Biomedical Recent Development
11.6 TeVido Biodevices
11.6.1 TeVido Biodevices Company Detail
11.6.2 TeVido Biodevices Business Overview
11.6.3 TeVido Biodevices 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.6.4 TeVido Biodevices Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.6.5 TeVido Biodevices Recent Development
11.7 Digilab
11.7.1 Digilab Company Detail
11.7.2 Digilab Business Overview
11.7.3 Digilab 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.7.4 Digilab Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.7.5 Digilab Recent Development
11.8 Advanced Solutions Life Sciences
11.8.1 Advanced Solutions Life Sciences Company Detail
11.8.2 Advanced Solutions Life Sciences Business Overview
11.8.3 Advanced Solutions Life Sciences 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.8.4 Advanced Solutions Life Sciences Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.8.5 Advanced Solutions Life Sciences Recent Development
11.9 TRS – Tissue Regeneration Systems
11.9.1 TRS – Tissue Regeneration Systems Company Detail
11.9.2 TRS – Tissue Regeneration Systems Business Overview
11.9.3 TRS – Tissue Regeneration Systems 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.9.4 TRS – Tissue Regeneration Systems Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.9.5 TRS – Tissue Regeneration Systems Recent Development
11.10 Nscrypt, Inc
11.10.1 Nscrypt, Inc Company Detail
11.10.2 Nscrypt, Inc Business Overview
11.10.3 Nscrypt, Inc 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.10.4 Nscrypt, Inc Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.10.5 Nscrypt, Inc Recent Development
11.11 EnvisionTEC
11.11.1 EnvisionTEC Company Detail
11.11.2 EnvisionTEC Business Overview
11.11.3 EnvisionTEC 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.11.4 EnvisionTEC Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.11.5 EnvisionTEC Recent Development
11.12 MedPrin
11.12.1 MedPrin Company Detail
11.12.2 MedPrin Business Overview
11.12.3 MedPrin 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.12.4 MedPrin Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.12.5 MedPrin Recent Development
11.13 Nano3D Sciences
11.13.1 Nano3D Sciences Company Detail
11.13.2 Nano3D Sciences Business Overview
11.13.3 Nano3D Sciences 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.13.4 Nano3D Sciences Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.13.5 Nano3D Sciences Recent Development
11.14 Rokit
11.14.1 Rokit Company Detail
11.14.2 Rokit Business Overview
11.14.3 Rokit 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.14.4 Rokit Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.14.5 Rokit Recent Development
11.15 Cellbricks
11.15.1 Cellbricks Company Detail
11.15.2 Cellbricks Business Overview
11.15.3 Cellbricks 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.15.4 Cellbricks Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.15.5 Cellbricks Recent Development
11.16 REGEMAT 3D
11.16.1 REGEMAT 3D Company Detail
11.16.2 REGEMAT 3D Business Overview
11.16.3 REGEMAT 3D 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.16.4 REGEMAT 3D Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.16.5 REGEMAT 3D Recent Development
11.17 Allevi
11.17.1 Allevi Company Detail
11.17.2 Allevi Business Overview
11.17.3 Allevi 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.17.4 Allevi Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.17.5 Allevi Recent Development
11.18 Poietis
11.18.1 Poietis Company Detail
11.18.2 Poietis Business Overview
11.18.3 Poietis 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.18.4 Poietis Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.18.5 Poietis Recent Development
11.19 T&R BIOFAB
11.19.1 T&R BIOFAB Company Detail
11.19.2 T&R BIOFAB Business Overview
11.19.3 T&R BIOFAB 3D Bioprinting for Tissue and Organ Regeneration Introduction
11.19.4 T&R BIOFAB Revenue in 3D Bioprinting for Tissue and Organ Regeneration Business (2019-2024)
11.19.5 T&R BIOFAB Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
BIOLIFE4D
Organovo
Celllink
Aspect Biosystems
Cyfuse Biomedical
TeVido Biodevices
Digilab
Advanced Solutions Life Sciences
TRS – Tissue Regeneration Systems
Nscrypt, Inc
EnvisionTEC
MedPrin
Nano3D Sciences
Rokit
Cellbricks
REGEMAT 3D
Allevi
Poietis
T&R BIOFAB
Ìý
Ìý
*If Applicable.
